The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications

被引：36
作者：
Capasso, Cristian [1 ]
Garofalo, Mariangela [2 ]
Hirvinen, Mari [1 ]
Cerullo, Vincenzo [1 ]
机构：
[1] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci & CDR, Lab Immunovirotherapy,Bioctr 2, Helsinki 00790, Finland
[2] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy
来源：
VIRUSES-BASEL | 2014年 / 6卷 / 02期
关键词：
gene therapy; adenoviral vectors; genetic modification; chimeric fibers; surface modification; pseudotyping; polymers; immunogenicity; re-targeting; INNATE IMMUNE-RESPONSE; POLYETHYLENE-GLYCOL MODIFICATION; COMPLEMENT REGULATORY PROTEINS; ONCOLYTIC ADENOVIRUS; RECOMBINANT ADENOVIRUS; IN-VIVO; VIRAL-ANTIGENS; FIBER SHAFT; INFLAMMATORY RESPONSE; REPLICATION-COMPETENT;
D O I：
10.3390/v6020832
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A long time has passed since the first clinical trial with adenoviral (Ad) vectors. Despite being very promising, Ad vectors soon revealed their limitations in human clinical trials. The pre-existing immunity, the marked liver tropism and the high toxicity of first generation Ad (FG-Ad) vectors have been the main challenges for the development of new approaches. Significant effort toward the development of genetically and chemically modified adenoviral vectors has enabled researchers to create more sophisticated vectors for gene therapy, with an improved safety profile and a higher transduction ability of different tissues. In this review, we will describe the latest findings in the high-speed, evolving field of genetic and chemical modifications of adenoviral vectors, a field in which different disciplines, such as biomaterial research, virology and immunology, co-operate synergistically to create better gene therapy tools for modern challenges.
引用
收藏
页码：832 / 855
页数：24
相关论文
共 139 条
[1]   Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrier [J].
Ahn, CH ;
Chae, SY ;
Bae, YH ;
Kim, SW .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (03) :567-574
[2]   Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus) [J].
Alba, R. ;
Bradshaw, A. C. ;
Mestre-Frances, N. ;
Verdier, J-M ;
Henaff, D. ;
Baker, A. H. .
GENE THERAPY, 2012, 19 (01) :109-113
[3]   Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors [J].
Alba, Raul ;
Bradshaw, Angela C. ;
Coughlan, Lynda ;
Denby, Laura ;
McDonald, Robert A. ;
Waddington, Simon N. ;
Buckley, Suzanne M. K. ;
Greig, Jenny A. ;
Parker, Alan L. ;
Miller, Ashley M. ;
Wang, Hongjie ;
Lieber, Andre ;
van Rooijen, Nico ;
McVey, John H. ;
Nicklin, Stuart A. ;
Baker, Andrew H. .
BLOOD, 2010, 116 (15) :2656-2664
[4]   Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer [J].
Alba, Raul ;
Bradshaw, Angela C. ;
Parker, Alan L. ;
Bhella, David ;
Waddington, Simon N. ;
Nicklin, Stuart A. ;
van Rooijen, Nico ;
Custers, Jerome ;
Goudsmit, Jaap ;
Barouch, Dan H. ;
Mcvey, John H. ;
Baker, Andrew H. .
BLOOD, 2009, 114 (05) :965-971
[5]   Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors [J].
Appledorn, D. M. ;
McBride, A. ;
Seregin, S. ;
Scott, J. M. ;
Schuldt, N. ;
Kiang, A. ;
Godbehere, S. ;
Amalfitano, A. .
GENE THERAPY, 2008, 15 (24) :1606-1617
[6]   Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting [J].
Bayo-Puxan, Neus ;
Cascallo, Manel ;
Gros, Alena ;
Huch, Meritxell ;
Fillat, Cristina ;
Alemany, Ramon .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :2487-2495
[7]   Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer [J].
Belousova, Natalya ;
Mikheeva, Galina ;
Gelovani, Juri ;
Krasnykh, Victor .
JOURNAL OF VIROLOGY, 2008, 82 (02) :630-637
[8]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[9]   Targeted therapies in bladder cancer - an update [J].
Black, Peter C. ;
Agarwal, Piyush K. ;
Dinney, Colin P. N. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :433-438
[10]   Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor [J].
Bonsted, Anette ;
Engesaeter, Birgit Ovstebo ;
Hogset, Anders ;
Maelandsmo, Gunhild M. ;
Prasmickaite, Lina ;
D'Oliveira, Christine ;
Hennink, Wim E. ;
van Steenis, Jan Hein ;
Berg, Kristian .
JOURNAL OF GENE MEDICINE, 2006, 8 (03) :286-297
12345678910